IFNG and neoplasm: Taken together, our unique IO assay platform provides evidence thatT-cell anti-tumor function can be profiled in a high-throughput industrial drugdiscovery setting and that small molecule targeted inhibitors can augment intrinsicproperties of T-cells either by upregulation of antigen recognition machinery and/orsecretion of IFNg.